SEC Form D private-offering filing
Praeventix, Inc.
A new SEC Form D private-offering notice from Exton, PA, a $5,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Clinical-stage biopharmaceutical company developing serotonergic therapeutics, including a topical 5-HT7 receptor antagonist for chronic pruritus.
Filed 2026-02-13Filed to raise $5,000,000First money in 2026-02-03Raised so far $3,000,000HQ (as filed) Exton, PASector Biotech ✓Stage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified praeventix.com↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.